|

Stellate Ganglion Block and Dexmedetomidine for Postoperative Sleep in Women Undergoing Laparoscopic Gynecologic Surgery

RECRUITINGN/ASponsored by Catherin Zhang
Actively Recruiting
PhaseN/A
SponsorCatherin Zhang
Started2026-10
Est. completion2026-12
Eligibility
Age18 Years – 75 Years
SexFEMALE
Healthy vol.Accepted

Summary

Study Objectives This study aims to investigate the effects of preoperative stellate ganglion block and intraoperative intravenous dexmedetomidine on postoperative sleep disturbance in patients undergoing laparoscopic gynecologic surgery, with the goals of reducing pain and postoperative adverse reactions and identifying an effective, safe, economical, and broadly applicable intervention strategy that may facilitate emergence from anesthesia, accelerate postoperative recovery, shorten the length of hospital stay, and reduce hospitalization costs. This trial aims to determine whether preoperative stellate ganglion block (SGB) and intraoperative intravenous dexmedetomidine (DEX) can improve postoperative sleep quality in patients undergoing laparoscopic gynecologic surgery, and whether the combination of these two interventions provides an interaction effect or additional ben

Eligibility

Age: 18 Years – 75 YearsSex: FEMALEHealthy volunteers accepted
Inclusion Criteria:

1. Patients with American Society of Anesthesiologists (ASA) physical status I-III;
2. Age 18-75 years;
3. Scheduled to undergo laparoscopic gynecologic surgery (laparoscopic hysterectomy or laparoscopic surgery for uterine fibroids).

Exclusion Criteria:

1. Preoperative sore throat or hoarseness;
2. History of upper respiratory tract infection within the previous 2 weeks;
3. Anticipated difficult tracheal intubation (Mallampati class III or IV, potential facial deformity, mouth opening \<3 finger breadths, etc.);
4. Severe preoperative cardiac, hepatic, renal, or other organ dysfunction;
5. Allergy to the local anesthetic used in the study, infection at the puncture site, or coagulation abnormalities;
6. Cognitive impairment, hearing impairment, language impairment, a history of psychiatric illness, or difficulty communicating or cooperating because of a psychiatric disorder.

Conditions7

Adenomyosis of UterusCancerCervical CancerEndometrial CancerEndometriosisOvarian CancerUterine Fibroids (Leiomyoma)

Interventions2

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.